Inventory increased 17.8%
Inventory changed +17.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$24.3M→$28.6M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →INGN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy decreased 39.0%
Free-cash-flow proxy changed -39.0% from the comparable as-filed period.
$3.7M→$2.2M3 prior comparisons
Operating cash flow decreased 32.3%
Operating cash flow changed -32.3% from the comparable as-filed period.
$4.4M→$2.9M3 prior comparisons
Operating margin moved 164 bp higher
Operating margin changed +164 basis points from the comparable as-filed period.
-7.74%→-6.10%2 prior comparisons
Operating income increased 16.9%
Operating income changed +16.9% from the comparable as-filed period.
-$6.1M→-$5.1M2 prior comparisons
Inventory / revenue moved 357 bp higher
Inventory / revenue changed +357 basis points from the comparable as-filed period.
30.71%→34.28%2 prior comparisons
Cash & equivalents decreased 15.8%
Cash & equivalents changed -15.8% from the comparable as-filed period.
$103.7M→$87.3M2 prior comparisons
Trade receivables increased 19.6%
Trade receivables changed +19.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$38.6M→$46.2M4 prior comparisons
Revenue increased 5.5%
Revenue changed +5.5% from the comparable as-filed period.
$79.2M→$83.5M2 prior comparisons
Receivables / revenue moved 652 bp higher
Receivables / revenue changed +652 basis points from the comparable as-filed period.
48.74%→55.26%2 prior comparisons
Gross margin moved 41 bp lower
Gross margin changed -41 basis points from the comparable as-filed period.
52.22%→51.81%2 prior comparisons
Shares outstanding decreased 1.9%
Shares outstanding changed -1.9% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes. This reverses 8 consecutive comparable moves in the opposite direction.
27,040,390→26,538,3378 prior comparisons
Net income increased 7.3%
Net income changed +7.3% from the comparable as-filed period.
-$4.2M→-$3.9M2 prior comparisons
Working capital decreased 9.4%
Working capital changed -9.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$136.1M→$123.3M4 prior comparisons
Total assets decreased 8.5%
Total assets changed -8.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$312.0M→$285.6M4 prior comparisons
Operating cash-flow margin moved 197 bp lower
Operating cash-flow margin changed -197 basis points from the comparable as-filed period.
5.49%→3.53%2 prior comparisons
Free-cash-flow margin moved 195 bp lower
Free-cash-flow margin changed -195 basis points from the comparable as-filed period.
4.63%→2.68%2 prior comparisons
Stock-based compensation decreased 22.8%
Stock-based compensation changed -22.8% from the comparable as-filed period.
$2.3M→$1.8M2 prior comparisons
Current assets decreased 4.4%
Current assets changed -4.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$203.1M→$194.1M4 prior comparisons
Current liabilities increased 5.7%
Current liabilities changed +5.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$67.1M→$70.9M4 prior comparisons
Research & development increased 12.7%
Research & development changed +12.7% from the comparable as-filed period.
$5.2M→$5.9M2 prior comparisons
Capex / revenue moved 1 bp lower
Capex / revenue changed -1 basis points from the comparable as-filed period.
0.86%→0.85%2 prior comparisons
Current ratio decreased 9.5%
Current ratio changed -9.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
3.03→2.744 prior comparisons
SBC / revenue moved 78 bp lower
SBC / revenue changed -78 basis points from the comparable as-filed period.
2.90%→2.12%2 prior comparisons
Capital expenditure increased 3.9%
Capital expenditure changed +3.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$684,000→$711,0003 prior comparisons
R&D / revenue moved 45 bp higher
R&D / revenue changed +45 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
6.58%→7.03%2 prior comparisons
Working capital / assets moved 43 bp lower
Working capital / assets changed -43 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
43.60%→43.17%4 prior comparisons
Gross profit increased 4.7%
Gross profit changed +4.7% from the comparable as-filed period.
$41.3M→$43.3M2 prior comparisons
Cost of revenue increased 1.7%
Cost of revenue changed +1.7% from the comparable as-filed period.
$50.9M→$51.8M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.